Login / Signup

GGPS1-associated muscular dystrophy with and without hearing loss.

Rauan KaiyrzhanovLuke Daniel PerryClarissa RoccaMaha S ZakiHeba HosnyCristiane Araujo Martins MorenoRahul PhadkeIrina T ZaharievaClara Camelo GontijoChristian BeetzVeronica PiniMojtaba MovahediniaEdmar ZanoteliStephanie DiTroiaSandrine Vuillaumier-BarrotArnaud IsapofMohammad Yahya Vahidi MehrjardiNasrin GhasemiAnna SarkozyFrancesco MuntoniSandra WhalenBarbara VonaHenry HouldenReza Maroofian
Published in: Annals of clinical and translational neurology (2022)
Ultra-rare biallelic pathogenic variants in geranylgeranyl diphosphate synthase 1 (GGPS1) have recently been associated with muscular dystrophy/hearing loss/ovarian insufficiency syndrome. Here, we describe 11 affected individuals from four unpublished families with ultra-rare missense variants in GGPS1 and provide follow-up details from a previously reported family. Our cohort replicated most of the previously described clinical features of GGPS1 deficiency; however, hearing loss was present in only 46% of the individuals. This report consolidates the disease-causing role of biallelic variants in GGPS1 and demonstrates that hearing loss and ovarian insufficiency might be a variable feature of the GGPS1-associated muscular dystrophy.
Keyphrases
  • muscular dystrophy
  • hearing loss
  • copy number
  • duchenne muscular dystrophy
  • intellectual disability
  • high resolution
  • autism spectrum disorder
  • replacement therapy
  • mass spectrometry
  • genome wide